Back to search
Auto Inflammatory Diseases
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Auto Inflammatory Diseases trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Auto Inflammatory Diseases trials you may qualify forBackground: Most people with tuberculosis (TB) feel better after starting treatment. But for some people, the opposite happens. They may feel better at first,…
The pathophysiology of certain inflammatory arthritides remains poorly understood, particularly when associated with rare systemic autoimmune diseases such as s…
The aim of this project is to start a biological and clinical collection of patients presenting autoimmune, dysimmune or auto-inflammatory dermatological diseas…
Rare diseases are defined as those that affect one person in 2,000, or around three million people in France. The majority of rare diseases are caused by geneti…
Inflammatory diseases may display atypical features making such patients impossible to classify. Management of these cases in daily practice cannot rely on the…
The objective of this work is to identify, in patients with autoimmune diseases, systemic vasculitis and autoinflammatory disease, cytokine and lymphocyte bioma…
We propose to study the intestinal secretion of ASCA by evaluating them in biopsy culture supernatants from a cohort of patients suffering from CD (n=80) and a…
This qualitative interview-based study aim to build a tool to assess quality of life in patients (adults or children) suffering from 6 autoinflammatory diseases…
SITRAME syndrome is a recently described disease. In the absence of epidemiological data on SITRAME syndrome in France, the National Reference Center for Autoin…